Biotech Aizen Therapeutics has spun out of the lab of David Van Valen at the California Institute of Technology with $13 million in seed funding. Aizen is using generative artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback